Cancer Archives

Healthcare Industry News Weekly Wrap-Up: September 2, 2022

// Biotech and Pharma Therapeutics Novartis Nabs Merck Veteran to Helm BioMedical Institutes September 1, 2022 / Novartis / Business / Oncology Merck veteran Fiona H. Marshall has been tapped as president of the Novartis Institutes for BioMedical Research (NIBR)....

September 2, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 25, 2022

// Biotech and Pharma Therapeutics Backed by $40M, a biotech startup targets cancer with help from the immune system August 16, 2022 / Cancer / Biotech / Startups M3T Biosciences is emerging from stealth with plans to develop therapies based...

August 25, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: August 4, 2022

// Biotech and Pharma Therapeutics Bayer-Ionis’ anti-thrombotic med doesn’t increase bleeding in phase 2, setting stage for a new type of anticoagulant July 28, 2022 / Bayer / Ionis Pharma / Blood Clots Patients with kidney disease taking Ionis Pharmaceuticals...

August 4, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: July 28, 2022

// Biotech and Pharma Therapeutics Is This Vertex Pharmaceuticals’ Biggest News Yet? July 25, 2022 Pain / VX-548 / Pharma It’s been a big year for Vertex Pharmaceuticals (VRTX -1.85%) so far. The biotech company has grown its main cystic...

July 28, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: July 21, 2022

// Biotech and Pharma Therapeutics UnitedHealth CSO says no nopay for insulin, other critical drugs from 2023 July 15, 2022 / Insulin / New Drugs / Drug Pricing The news comes amid heightened public scrutiny over soaring prices of the...

July 21, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 7, 2022

// Biotech and Pharma Therapeutics Lilly’s tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo Nordisk’s Wegovy October 6, 2022 / Eli Lilly / Tirzepatide / Mounjaro / U.S. FDA Thursday, Lilly said the FDA flagged...

March 28, 2022

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: November 19, 2021

// Biotech and Pharma Therapeutics J&J sees potential for 14 new multibillion-dollar drugs by 2025 November 18, 2021 / J&J / Drug Pricing / 2025 Johnson & Johnson (JNJ.N) expects to file for approval of 14 new drugs by 2025, and has...

November 19, 2021

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: October 1, 2021

// Biotech and Pharma Therapeutics Currax Pharmaceuticals Hosted Ribbon-cutting Ceremony to Mark the Opening of its Nashville Headquarters October, 2021 / ChemoCentryx / FDA / Autoimmune Disease Currax Parmaceuticals, LLC (“Currax”). a specialty biopharmaceutical company dedicated to expanding access to...

October 1, 2021

Weekly Wrap-Up

Healthcare Industry News Weekly wrap-Up: September 23, 2021

September 23, 2021

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: September 16, 2021

// Biotech and Pharma Therapeutics Philip Morris takes control of Vectura amid pushback against acquisition September 17, 2021 / Philip Morris / Vectura / Acquisition The attempt to buy Vectura has been more challenging and fractious than the other deals,...

September 16, 2021

1 2 … 6 7 8

Tag: Cancer

Healthcare Industry News Weekly Wrap-Up: September 2, 2022

Healthcare Industry News Weekly Wrap-Up: August 25, 2022

Healthcare Industry News Weekly Wrap-Up: August 4, 2022

Healthcare Industry News Weekly Wrap-Up: July 28, 2022

Healthcare Industry News Weekly Wrap-Up: July 21, 2022

Healthcare Industry News Weekly Wrap-Up: October 7, 2022

Healthcare Industry News Weekly Wrap-Up: November 19, 2021

Healthcare Industry News Weekly Wrap-Up: October 1, 2021

Healthcare Industry News Weekly wrap-Up: September 23, 2021

Healthcare Industry News Weekly Wrap-Up: September 16, 2021

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy⁺

About Vault

Tag: Cancer

Contact Us

Vault Bioventures HQ

Maximize Innovation

Strategic Clarity

Strategy+

About Vault

Strategy⁺